Use this internal resource to keep sourcing, documentation, and RFQ discussion on the same page.
Reference B2B wholesale presentation: unbranded Type I neutral borosilicate glass lyophilized vials (3 mL / 10 mL) and plain white 10-vial protective divider box.
Reference B2B wholesale presentation: unbranded Type I neutral borosilicate glass lyophilized vials (3 mL / 10 mL) and plain white 10-vial protective divider box.
BPC-157 10mg + TB-500 10mg Co-Formulated Vial
Co-formulated vial containing BPC-157 10mg and TB-500 10mg, for qualified B2B sourcing, with per-component batch documentation and a stated TB-500 specification type.
Review specifications, files, and next-step support before requesting samples.
- Confirm the peptide name, CAS, and core specifications
- Check typical applications and document availability
- Use one inquiry path for pricing, files, samples, or project discussion
Quick Answer
Co-lyophilized BPC-157 + TB-500 blends: dual-peak HPLC & fragment identity check
Naming comparison table
| Name / term | How buyers should read it | RFQ action |
|---|---|---|
| BPC-157 + TB-500 (5mg/5mg or 10mg/10mg) | Standard 1:1 co-lyophilized dual-peptide vial in 3 mL neutral borosilicate glass. | Verify individual mg per component and separated RP-HPLC retention times. |
| 3- / 4-Component Repair Blends | Custom scheduled co-lyophilized formats combining GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) ± KPV (10 mg). | Sized in 5 mL neutral borosilicate vials with component-resolved HPLC assay. |
| TB-500 vs. Thymosin β4 Nomenclature | Market shorthand "TB-500" can denote either the 43-AA Tβ4 sequence or specific active fragments. | Always lock exact amino-acid sequence, CAS, and target ESI-MS molecular weight on the RFQ. |
B2B specification review table
| Review item | Buyer check |
|---|---|
| Component-resolved HPLC | Ensure the analytical method resolves BPC-157 and TB-500 peaks cleanly rather than reporting one merged purity figure. |
| ESI-MS dual-mass identity | Confirm both expected molecular ion masses appear in LC-MS verification of the blended batch. |
| Packaging & wholesale tracks | Unbranded neutral borosilicate 10-vial white boxes from stock or 4–6 week scheduled custom-ratio runs with 20+ cap colors. |
Use this internal resource to keep sourcing, documentation, and RFQ discussion on the same page.
Use this internal resource to keep sourcing, documentation, and RFQ discussion on the same page.
Key Review Snapshot
Key Review Snapshot
Calculate target mg/mL concentration, gross lyophilizate overfill (HPLC purity × net peptide content), and μM molarity.
Compare Track A (~5–7 day stock dispatch) vs. Track B (4–6 week custom runs) and 60-day sample credit.
Verify our exhibiting entity (Suzhou Xilin Technology Co., Ltd.), booth photos, and on-site COA/HPLC review.
Why buyers trust WUMO
Real content, documented — not guesswork
In peptide sourcing, chromatographic purity and delivered quantity require separate evaluation. We keep purity and labeling basis distinct on available documentation, so buyers can review analytical parameters for their quoted batch before ordering.
Purity vs quantity distinction
Purity (%) and reported quantity are distinct analytical parameters. Review purity and reported quantity separately, and confirm the labeling and assay basis for the batch proposed for your order.
Batch-specific documents
Batch documentation reflects the specific lot produced. Ask which batch-specific documents are available for the quoted lot, including COA and supporting HPLC or MS records where applicable.
Documented before commitment
Ingredient identity (INCI / CAS), specification sheet, and SDS are available for technical review. Confirm documentation for the batch proposed for your order before purchase.
Documents Available
Documents Available
COA
Batch-specific COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
HPLC purity report
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
MS identity report
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
SDS
SDS / MSDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Spec
Product specification sheet
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
Overview
B2B Review Guide
B2B Review Guide
Product Overview
This is a co-formulated lyophilized vial containing two peptides: BPC-157 at 10mg and TB-500 at 10mg. It is supplied for qualified B2B research sourcing projects. This page describes sourcing and analytical documentation only; it does not describe biological action, combination rationale, end-user application, or product performance.
“TB-500” needs to be pinned down in writing
The name “TB-500” is used inconsistently across the commercial peptide market. In the analytical literature it generally refers to an N-acetylated thymosin β4 fragment, whereas some commercial catalogues apply the same name to full-length thymosin β4. Those are chemically different materials with different molecular weights and different costs.
The specification supplied here is a fragment, not full-length thymosin β4. That is stated openly because it is the most common place for a buyer to be surprised after delivery. Confirm the exact sequence or molecular specification in writing before ordering, and check it against the molecular weight shown on the identity record — the spectrum will tell you which material you have. If a supplier will not state which one they are quoting, that answer is itself informative.
What to check on a blended vial
- Component-level documentation. The analytical record should distinguish BPC-157 from TB-500 and state how identity and purity were assessed for each. Where a component-specific RP-HPLC purity figure is given, the method needs adequate chromatographic separation to support it.
- The ratio is part of the specification. 10mg + 10mg and 10mg + 5mg are different products, and the ratio belongs in the written specification and on the label.
- Total weight is not total peptide. Counterion content, residual moisture, and any excipient sit inside the vial weight — confirm what the per-vial claim is measured against.
What WUMO Can Supply
- Co-formulated vials at the 10mg + 10mg specification as standard
- Alternative ratios and fill quantities by project
- Batch-specific COA distinguishing the two components
- Neutral-label or private-label packaging, with components and ratio stated on the label
- Single-component vials as an alternative — see BPC-157 vial supply and TB-500 vial supply
- MOQ, lead time, and phased delivery planning
Quality and Documentation
A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.
Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.
Compliance Note
This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.
Specification and documentation references
- Lyophilized vial sourcing guide — fill amount, packaging, MOQ and documentation.
- What a 10mg vial actually contains — peptide content, counterion, moisture and excipients.
- How peptide identity is confirmed by mass spectrometry — what an identity record can and cannot establish.
FAQ
Frequently Asked Questions
How do you verify the ratio of each peptide inside a co-lyophilized blend vial?
Each peptide raw lot is first qualified individually by RP-HPLC and LC-MS prior to compounding, and the finished co-lyophilized vial lot is checked using an analytical RP-HPLC gradient that separates each component peak against reference standards.
Which TB-500 is in this vial?
A fragment specification, not full-length thymosin β4. Because the trade name is applied inconsistently, confirm the exact sequence in writing and check it against the molecular weight on the identity record.
Should a blended vial have one COA or two sets of results?
One COA is fine, but it should distinguish the components and say how identity and purity were assessed for each. A single combined purity figure does not adequately describe either component.
Can the ratio be changed?
Yes, alternative ratios and fill quantities are set per project, and whatever is agreed should appear in the written specification and on the vial label.
What should I send to get a quotation?
Company and business type, destination market, intended business use, required documentation package, target ratio and fill quantity, vial count, packaging preference, and required timeline.
Wholesale Distribution & OEM Private Label
Sourcing BPC-157 10mg + TB-500 10mg Co-Formulated Vial for regional distribution or your own brand?
Compare 7-day ready stock (unbranded 100% Type I neutral borosilicate vials in plain white 10-vial kits) against 4–6 week scheduled factory production with 60-day blind-test sample price credit, 20+ flip-off cap colors, standard lot-matched COA + RP-HPLC + LC-MS, and optional project-specified LAL/uniformity QC: see our Regional Distributor Program or Private-Label Vial OEM Service.
Request Pricing, Files, or Samples
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.